Raaj Trivedi, BioClinica's VP Commercial Operations, just received 17,500 options from the company. The strike price of the options received was $1.34, and these expire on February 28, 2026. Trivedi now owns at least 17,500 options on the company.
Some additional info was provided as follows:
25% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (2/29/16) with the balance vesting in equal monthly installments thereafter until fully vested on February 29, 2020.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To re ceive a free e-mail notification whenever BioClinica makes a similar move, sign up!
Other recent filings from the company include the following:
Biocept Just Filed Its Quarterly Report:
10. Net Loss per Co... - May 15, 2017
Securities to be offered to employees in employee benefit plans - May 15, 2017
Biocept Reports First Quarter 2017 Financial Results - May 11, 2017
Biocept: With Respect To Restricted Awards, The Restricted Period Sha - May 5, 2017